Neil Moat

Cardiac surgeon
Royal Brompton Hospital - London, United Kingdom

Latest contributions

Case-based learning for the Heart Valve Team: percutaneous mitral valve repair using artificial chords

26 Sep 2017 – From PCR London Valves 2017

Consult this case-based learning for the Heart Valve Team on percutaneous mitral valve repair. Learn more about the technique of percutaenous mitral valve repair with artificial chord: a 53-year-old male, with severe mitral regurgitation and very low risk profile.

RAPID FIRE: innovations in percutaneous tricuspid intervention

Consult this session to fully understand the anatomical and technical challenges associated with percutaneous tricuspid intervention, get an update on cutting-edge technologies with first-in-man experience, and then, identify the limitations of devices.

Case-based learning for the Heart Valve Team: hybrid techniques for percutaneous mitral valve repair

26 Sep 2017 – From PCR London Valves 2017

A transfemoral TAVI with Evolut Pro valve

26 Sep 2017 – From PCR London Valves 2017

Consult this session on a transfemoral TAVI with Evolut Pro valve, which includes a LIVE demonstration from Universitäres Herzzentrum - Rostock, Germany.

Randomised trials of TAVI in intermediate-risk patients - Implications for everyday practice

25 Sep 2017 – From PCR London Valves 2017

Transcatheter mitral valve replacement - Part I

25 Sep 2017 – From PCR London Valves 2017

Introduction to the PCR London Valves 2017 Mitral and Tricuspid track - The key questions in Mitral and Tricuspid Valve Intervention: where are we in 2017?

25 Sep 2017 – From PCR London Valves 2017

Transcatheter treatment of mitral regurgitation

18 May 2017 – From EuroPCR 2017

Consult this session on the transcatheter treatment of mitral regurgitation if you want to learn more about mitral valve anatomy and the implications for percutaneous treatment of mitral regurgitation, understand the importance of echocardiography in device selection and appreciate the advantages and disadvantages of different percutaneous treatment options.

Achieving immediate TAVI patient benefit and setting-up for superior long-term outcomes

17 May 2017 – From EuroPCR 2017

Will SURTAVI change my practice: TAVI for patients with intermediate risk?

16 May 2017 – From EuroPCR 2017

Will SURTAVI change my practice: TAVI for patients with intermediate risk? In this session, review the trial results for SURTAVI, learn how patient selection defines outcomes in TAVI and AVR and relate the findings of this trials to your patient population and practice.

LIVE demonstration: TAVI in a bicuspid aortic valve

20 Sep 2016 – From PCR London Valves 2016

Consult this session video if you want to learn more about TAVI in a bicuspid aortic valve, which includes a LIVE demonstration from Swiss Cardiovascular Centre, Bern University Hospital - Bern, Switzerland.

Clinical case

A 74-year-old male with bicuspid aortic stenosis:

Conscious sedationTransfemoral accessWith pre-dilatation
Prof. Jeroen J. Bax

Chairperson

Jeroen Bax
Dr. Alec Vahanian

Chairperson

Alec Vahanian

Moving TAVI to lower-risk populations

19 Sep 2016 – From PCR London Valves 2016

Darren Mylotte

Chairperson

Darren Mylotte
Prof. Olaf Wendler

Chairperson

Olaf Wendler

LIVE demonstration: Percutaneous edge-to-edge repair for mixed functional and degenerative mitral regurgitation using a next generation device

20 Sep 2016 – From PCR London Valves 2016

Martine Gilard

Chairperson

Martine Gilard
Prof. Olaf Wendler

Chairperson

Olaf Wendler

Trials and registries 2016: what do they mean?

20 Sep 2016 – From PCR London Valves 2016

Consult this session video on the trials and registries 2016 from PCR London Valves 2016.

Martine Gilard

Chairperson

Martine Gilard
Prof. Olaf Wendler

Chairperson

Olaf Wendler

Driving excellent patient outcomes today and tomorrow

20 Sep 2016 – From PCR London Valves 2016

Chairperson

Jeffrey J. Popma
Dr. Didier Tchétché

Chairperson

Didier Tchétché

Trialign: transcatheter annuloplasty for the treatment of tricuspid regurgitation

19 May 2016 – From EuroPCR 2016

Chairperson

Neil Moat

Direct Flow Medical innovations in the aortic and mitral programmes

18 May 2016 – From EuroPCR 2016

Chairperson

Jeffrey J. Popma

All you need to know about percutaneous mitral valve repair

18 May 2016 – From EuroPCR 2016

Dr. Alec Vahanian

Chairperson

Alec Vahanian

Chairperson

Neil Moat

Clinical outcomes after mitral & tricuspid valve interventions

22 Sep 2015 – From PCR London Valves 2015

Hueseyin Ince

Chairperson

Hüseyin Ince

Native mitral valve interventions

21 Sep 2015 – From PCR London Valves 2015

Valve-in-valve interventions: now the gold standard treatment for bioprosthetic failure?

21 May 2015 – From EuroPCR 2015

Watch this session video from EuroPCR 2015 on valve-in-valve interventions: now the gold standard treatment for bioprosthetic failure?

TAVI in intermediate-risk patients - What should we be doing now?

20 May 2015 – From EuroPCR 2015

Consult this session video from EuroPCR 2015 on TAVI in intermediate-risk patients: what should we be doing now?

Michael Haude

Chairperson

Michael Haude

Tips and Tricks

16 Sep 2013 – From PCR London Valves 2013

What is the known unknown about TAVI?

16 Sep 2013 – From PCR London Valves 2013

Prof. Alain Cribier

Chairperson

Alain Cribier

Chairperson

Neil Moat